Pharmacoeconomics and Quality of Life: Evaluating the Economic and Social Impact of Pharmaceuticals

References

• McGhan W. F. Pharmacoeconomics and the evaluation of drugs and services. Hasp. Form. 1993; 28: 365–378
   PubMedGoogle Scholar
• McGhan W., Rowland C., Bootman J. L. Cost-benefit and cost-effectiveness: Methodology for evaluating clinical pharmacy service. Am. J. Hosp. Pharm. 1978; 35: 133–140
   PubMedGoogle Scholar
• Ray M. Administration direction for clinical practice. Am. J. Hosp. Pharm. 1979; 36: 308
   PubMedGoogle Scholar
• Bootman J. L., McGhan W. F., Schondelmeyer S. W. Application of cost-benefit and cost-effectiveness analysis to clinical practice. Drug Intell. Clin. Pharm. 1982; 16: 235–243
   PubMedGoogle Scholar
• McGhan W. F., Lewis N. J. Guidelines for pharmacoeconomic studies. Clin. Ther. 1992; 5: 486–494
   Google Scholar
• Enright S. M. Changes in health-care financing resulting from the 1984 federal budget. Am. J. Hosp. Pharm. 1983; 40: 835–838
   Google Scholar
• Curtiss F. R. Current concepts in hospital reimbursement. Am. J. Hosp. Pharm. 1983; 40: 586–591
   PubMedGoogle Scholar
• Weinstein M. C., Stason B. Foundations and cost-effectiveness analysis for health and medical practitioners. N. Engl. J. Med. 1977; 296: 716–721
   PubMed Web of Science ®Google Scholar
• Shepard D. S., Thompson M. S. First principles of cost-effectiveness analysis in health. Public Health Rep. 1979; 94: 535–544
   PubMed Web of Science ®Google Scholar
• Crystal R., Brewster A. Cost-benefit and cost-effectiveness analysis in the health field: an introduction. Inquiry 1966; 3: 3–13
   Google Scholar
• Acton J. Measuring the monetary value of life-saving programs. Law Contemp. Prob. 1976; 40: 46–72
   Google Scholar
• Emlet H. E., Jr. Use of cost-benefit analysis in solutions to national health problems. Presented at the 1968 Joint National Meeting of the Operations Research Society of America, San Francisco, California, May, 1–31968
   Google Scholar
• Gellman D. D. Cost-benefit in health care: we need to know more. Canc. Med. Assoc. J. 1974; 4: 998–999
   Google Scholar
• Goldschmidt P. G. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment. Inquiry 1976; 13: 29–47
   PubMedGoogle Scholar
• Bootman J. L., et al. Individualizing gentamicin dosage regimens on burn patients with gram-negative septicemia: a cost-benefit analysis. J. Pharm. Sci. 1979; 68: 261–212
   PubMedGoogle Scholar
• Bootman J. L., et al. Individualization of aminoglycoside dosage regimens: a cost analysis. Am. J. Hosp. Pharm. 1979; 36: 368
   PubMedGoogle Scholar
• Strange P. V., Sumner A. T. Predicting treatment costs and life expectancy for end-stage renal disease. N. Engl. J. Med. 1978; 298: 312–318
   Google Scholar
• Cretin S. Cost-benefit analysis of treatment and prevention of myocardial infarction. Health Serv. Res. 1977; 12: 174–189
   PubMed Web of Science ®Google Scholar
• Mattsson W., et al. Cancer chemotherapy in advanced malignant disease: a cost-benefit analysis. Acta Radiol. Oncol. 1979; 18: 509–520
   Google Scholar
• Stason W., Weinstein M. Allocation of resources to manage hypertension. N. Engl. J. Med. 1977; 296: 132
   PubMedGoogle Scholar
• Estershan R. J., Jr., et al. Cost analysis of leukemia treatment: a problem-oriented approach. Cancer 1976; 37: 646–52
   PubMed Web of Science ®Google Scholar
• Bryers F., Hawthorne V. M. Screening for mild hypertension: costs and benefits. J. Epidemiol. Commun. Health 1978; 32: 171–174
   PubMed Web of Science ®Google Scholar
• Kissick W. L. Cost-benefit studies in health planning in the U.S.A. Health Econ. 1969; 42: 39–44
   Google Scholar
• Klarman H. Application of cost-benefit analysis to health services and the special case of technological innovation. Int. J. Health Serv. Res. 1974; 4: 325–352
   PubMed Web of Science ®Google Scholar
• Klarman H. Present status of cost-benefit analysis in the health field. Am. J. Public Health 1967; 57: 1948–1958
   Web of Science ®Google Scholar
• Smith W. Cost-effectiveness and cost-benefit for public health programs. Public Health Rep. 1968; 83: 899–906
   PubMed Web of Science ®Google Scholar
• Mushkin S., D'Accolings F. Economic cost of disease and injury. Public Health Rep. 1959; 74: 338–345
   PubMedGoogle Scholar
• Pigou A. C. Socialism Versus Capitalism, 129. Macmillan Press, London 1947
   Google Scholar
• Prest A. R., Turvey R. Cost-benefits analysis: a survey. Economist J. 1965; 75: 683–735
   Web of Science ®Google Scholar
• Peters G. H. Cost/Benefit Analysis and Public Expenditures, Paper 8. Institute of Economic Affairs, London 1968
   Google Scholar
• Osteryoung J. Capital Budgeting: Long-Term Asset Selection. Grid Inc., Columbus, OH 1974
   Google Scholar
• Silvers J. B., Praholed C. K. Financial Management of Health Institutions. Spectrum Publications, New York 1974
   Google Scholar
• Van Home J. C. Financial Management and Policy. Prentice-Hall, Englewood Cliffs, NJ 1974
   Google Scholar
• Torrance G. A generalized cost-effectiveness model for evaluation of health programs. State University of New York at Buffalo. 1971, Ph.D. Dissertation
   Google Scholar
• Klarman H. Application of cost-benefit analysis to health services technology. J. Occup. Med. 1974; 18: 172–186
   Google Scholar
• Schulbert H. C., Sheldon C. A., Baker F. Program Evaluation in the Health Field. Behavioral Publications, New York 1969
   Google Scholar
• Rice D. P. Measurement and application of illness costs. Public Health Rep. 1969; 84: 91–101
   PubMedGoogle Scholar
• Rice D. P. Estimating the cost of illness, Health Economics Series No. 6. U.S. Government Printing Office, Washington, DC 1966
   Google Scholar
• Rinehard K., Felsman F., Moody L. Time loss and indirect economic cost caused by disease among Indian and Alaskan natives. Public Health Rep. 1970; 85: 402
   Google Scholar
• Ridker R. G. Economic Cost of Air Pollution. Praeger, New York 1967
   Google Scholar
• Mishan E. J. Evaluation of life and limb: an theoretical approach. Benefit/Cost Analysis, A. Harberger, et al. Aldine-Atherton, Chicago 1971; 103–123
   Google Scholar
• Packer A. H. Applying cost-effectiveness concepts to the community health system. Oper. Res. 1968; 16: 227–253
   Web of Science ®Google Scholar
• Klarman H. Economics of Health. Columbia University Press, New York 1965
   Google Scholar
• Marglin S. A. The social rate of discount at the optimal rate of investment. J. Econ. 1963; 77: 95–111
   Google Scholar
• Baumol W. J. On the discount rate for public projects. Public Expenditures and Policy Analysis, R. Haveman, J. Margolia. Markham, Chicago 1970; 273–290
   Google Scholar
• Amadio J., Mueller J., Grey R. Benefit/cost ratio. Public Health Report. Illinois Department of Public Health, Southern Illinois University, Carbondale and Jackson County Health Department. 1976
   Google Scholar
• Joehnk M., McGrail G. R., Degal N. J. Application of a benefit/cost model to family practice Nes Denz. U.S. Government Printing Office, Washington, DC 1975, Prepared by the Department of Health, Education and Welfare. National Technical Information Service No. HRP-0007312
   Google Scholar
• Cohn E. Public Expenditures Analysis. DC Heath, Lexington, MA 1972
   Google Scholar
• Ruchlin, Rogers. Economics and Health Care. Charles C. Thomas, Springfield, IL 1973
   Google Scholar
• Mishan E. J. Cost-Benefit Analysis. Hold, Rinehart and Winston, New York 1976
   Google Scholar
• Quade E. S. Introduction and overview. Cost-Effectiveness Analysis, T. A. Goldin. Praeger, New York 1967
   Google Scholar
• Niskanen W. A. Measurement of effectiveness. Cost-Effectiveness Analysis, T. A. Goldman. Praeger, New York 1967
   Google Scholar
• Weinstein M. C., Stason B. Foundations and cost-effectiveness analysis for health and medical practitioners. N. Engl. J. Med. 1977; 296: 716–721
   PubMed Web of Science ®Google Scholar
• Bottman J. L., Townsend R. B., McGhan W. F. Principles of Pharmacoeconomics. Harvey Whitney Books, Chicago 1991
   Google Scholar
• Ellwood P. M. Outcomes management: a technology of patient experience. N. Engl. J. Med. 1988; 18: 1549–1556
   Google Scholar
• MacKeigan L. D., Pathak D. S. Overview of health-related quality-of-life measures. Am. J. Hosp. Pharm. 1992; 49: 2236–45
   PubMedGoogle Scholar
• Einarson T. R., McGhan W. F., Bootman J. L. Decision analysis applied to pharmacy practice. Am. J. Hosp. Pharm. 1985; 42: 364–371
   PubMedGoogle Scholar
• Wennberg J. E. The paradox of appropriate care. JAMA 1987; 258: 2568–2569
   PubMed Web of Science ®Google Scholar
• McGhan W. F., Smith M. D. Improving the cost-benefits of pharmaceutical services: pharmacoeconomics 101. Pharm. Business 1993; Spring: 6–10
   Google Scholar